CONNECT WITH US
AI & Deeptech

AI & Deeptech

Can AI help build a healthier future?

Microsoft Research logo

Published on

Add as a preferred source on Google
Can AI help build a healthier future?

Technical advancement is moving at such a rapid pace that it can be challenging to define the tomorrow we’re working toward. In The Shape of Things to Come, Microsoft Research leader Doug Burger and experts from across disciplines tease out the thorniest AI issues facing technologists, policymakers, business decisionmakers, and other stakeholders today. The goal: to amplify the shared understanding needed to build a future in which the AI transition is a net positive.

Microsoft Principal Research Manager Ava Amini, Microsoft Chief Scientific Officer Eric Horvitz, and physician-scientist and Microsoft AI health advisor Eric Topol (opens in new tab) of Scripps Research join Burger to tackle a question with ramifications for every individual on the planet: What might the future of medicine look like with AI, and what needs to happen first?

Drawing from experiences in machine learning, bioscience, and clinical care, the group explores AI-assisted medical diagnosis, the untapped potential of leveraging AI in medical imaging, whole-patient models, virtual cells, and the role of biological foundation models in scientific discovery. The group also examines why promising research can be slow to reach patients, how AI could guide experiments and drug discovery, and why better biological data and real-world validation remain essential.

This episode delivers a research-grounded conversation of what AI can do today in the health space, the challenges and opportunities still ahead, and the shape of things to come.

DOUG BURGER: This is The Shape of Things to Come, a Microsoft Research Podcast. I’m your host, Doug Burger.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.